Personal information

Activities

Collapse all

Education and qualifications (4)

University of Pittsburgh School of Medicine: Pittsburgh, PA, US

2021 to 2027 | Doctor of Medicine
Education
Source: Self-asserted source
Stephen C. Frederico

Harvard University: Cambridge, US

2023 to 2025 | Master of Medical Science (Clinical Investigation)
Education
Source: Self-asserted source
Stephen C. Frederico

Johns Hopkins University: Baltimore, Maryland, US

2019 to 2021 | Master of Science (Biotechnology)
Education
Source: Self-asserted source
Stephen C. Frederico

College of Charleston: Charleston, SC, US

2015 to 2019 | Bachelor of Arts (Biological Sciences)
Education
Source: Self-asserted source
Stephen C. Frederico

Funding (3)

Targeting Metabolic Vulnerabilities in Combination with Avapritinib in Diffuse Midline Glioma

2023 to 2024 | Grant
Physician Scientist Support Foundation (Durham, North Carolina, US)
URL: https://www.pediatrics.pitt.edu/news/pitt-med-student-awarded-research-grant-study-pediatric-brain-tumors
Source: Self-asserted source
Stephen C. Frederico

Developing an Adoptive Cell Transfer Immunotherapy for Pediatric Brain Tumors

2022 to 2023 | Grant
American Brain Tumor Association (Chicago, Illinois, US)
URL: https://www.pitt.edu/pittwire/accolades-honors/stephen-frederico-abta-fellowship
Source: Self-asserted source
Stephen C. Frederico

The Creation of a T-Cell Receptor-Engineered T-cell (TCR-T) Therapy for Glioblastoma

2022 to 2023 | Grant
Henry L. Hillman Foundation (Pittsburgh, Pennsylvania, US)
URL: https://www.utimes.pitt.edu/accolades/stephen-frederico
Source: Self-asserted source
Stephen C. Frederico

Works (15)

Transcriptomic observations of intra and extracellular immunotherapy targets for pediatric brain tumors

Expert Review of Clinical Immunology
2024-11 | Journal article
DOI: 10.1080/1744666X.2024.2390023
Contributors: Stephen C. Frederico; Itay Raphael; Michal Nisnboym; Sakibul Huq; Brent T. Schlegel; Chaim T. Sneiderman; Sydney A. Jackson; Anya Jain; Michael R. Olin; Brian R. Rood et al.
Source: check_circle
Crossref

Barriers to T Cell Functionality in the Glioblastoma Microenvironment

Cancers
2024-09-26 | Journal article
DOI: 10.3390/cancers16193273
Contributors: Noor E. Nader; Stephen C. Frederico; Tracy Miller; Sakibul Huq; Xiaoran Zhang; Gary Kohanbash; Constantinos G. Hadjipanayis
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Heterogeneous clinicopathological findings and patient-reported outcomes in adults with MN1-altered CNS tumors: A case report and systematic literature review

Frontiers in Oncology
2023 | Journal article
DOI: 10.3389/fonc.2023.1099618
EID:

2-s2.0-85147312457

Part of ISSN: 2234943X
Contributors: Frederico, S.C.; Vera, E.; Abdullaev, Z.; Acquaye, A.; Aldape, K.; Boris, L.; Briceno, N.; Choi, A.; Christ, A.; Cooper, D. et al.
Source: Self-asserted source
Stephen C. Frederico via Scopus - Elsevier

Neoadjuvant immune checkpoint inhibition in the management of glioblastoma: Exploring a new frontier

Frontiers in Immunology
2023 | Journal article
DOI: 10.3389/fimmu.2023.1057567
EID:

2-s2.0-85149540588

Part of ISSN: 16643224
Contributors: Frederico, S.C.; Darling, C.; Bielanin, J.P.; Dubinsky, A.C.; Zhang, X.; Hadjipanayis, C.G.; Kohanbash, G.
Source: Self-asserted source
Stephen C. Frederico via Scopus - Elsevier

Pre-clinical models for evaluating glioma targeted immunotherapies

Frontiers in Immunology
2023 | Journal article
DOI: 10.3389/fimmu.2022.1092399
EID:

2-s2.0-85146673941

Part of ISSN: 16643224
Contributors: Frederico, S.C.; Zhang, X.; Hu, B.; Kohanbash, G.
Source: Self-asserted source
Stephen C. Frederico via Scopus - Elsevier

NEIM-01 IMMUNOSUPPRESSION IN THE GLIOMA MICROENVIRONMENT: USING PET IMAGING TO HIGHLIGHT THE PRESENCE OF TIGIT

Neuro-oncology advances
2023-08-01 | Journal article
PMC: PMC10402362
Source: Self-asserted source
Stephen C. Frederico

IMG-02. VISUALIZATION OF TIGIT IN THE GLIOMA MICROENVIRONMENT: THE CREATION OF A PET IMAGING TRACER

Neuro-oncology
2023-06-01 | Journal article
PMC: PMC10260062
Source: Self-asserted source
Stephen C. Frederico

Developing an adoptive cell transfer immunotherapy for pediatric high-grade gliomas

Regular and Young Investigator Award Abstracts
2022-11 | Conference abstract
DOI: 10.1136/jitc-2022-sitc2022.0222
Contributors: Chaim Sneiderman; Ian Pollack; Gary Kohanbash
Source: Self-asserted source
Stephen C. Frederico

Circulating tumor DNA – A potential aid in the management of chordomas

Frontiers in Oncology
2022-10-20 | Journal article
DOI: 10.3389/fonc.2022.1016385
Part of ISSN: 2234-943X
Contributors: Stephen C. Frederico; Corbin Darling; Xiaoran Zhang; Sakibul Huq; Sameer Agnihotri; Paul A. Gardner; Carl H. Snyderman; Eric W. Wang; Georgios A. Zenonos
Source: Self-asserted source
Stephen C. Frederico
grade
Preferred source (of 2)‎

Exploring the origin of the cancer stem cell niche and its role in anti-angiogenic treatment for glioblastoma

Frontiers in Oncology
2022-08-25 | Journal article
DOI: 10.3389/fonc.2022.947634
Part of ISSN: 2234-943X
Contributors: Funto A. Akindona; Stephen C. Frederico; John C. Hancock; Mark R. Gilbert
Source: Self-asserted source
Stephen C. Frederico
grade
Preferred source (of 2)‎

An innovative virtual multi-institutional, multidisciplinary neuro-oncology tumor board: The NIH-NOB experience during the COVID-19 pandemic

Neuro-Oncology
2021-11-12 | Conference abstract
DOI: 10.1093/neuonc/noab196.438
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Contributors: James Rogers; Alvina Acquaye; Ukeme Ikiddeh-Barnes; Kaitlyn Benson; Lisa Boris; Funto Akindona; Stephen Frederico; Varna Jammula; Yeonju Kim; Michael Timmer et al.
Source: Self-asserted source
Stephen C. Frederico

Immune checkpoint inhibitor nivolumab in people with recurrent select rare CNS cancers: Results of interim analysis in a heavily pretreated cohort

Neuro-Oncology
2021-11-12 | Conference abstract
DOI: 10.1093/neuonc/noab196.224
Part of ISSN: 1522-8517
Part of ISSN: 1523-5866
Contributors: Marta Penas-Prado; Ying Yuan; Kathleen Wall; Elizabeth Vera; Ukeme Ikiddeh-Barnes; Katie Blackburn; Claudia Chambers; Nivi Ratnam; Stephen Frederico; Alvina Acquaye et al.
Source: Self-asserted source
Stephen C. Frederico

Reversing Epigenetic Gene Silencing to Overcome Immune Evasion in CNS Malignancies.

Frontiers in oncology
2021-07-15 | Journal article
DOI: 10.3389/fonc.2021.719091
PMID: 34336705
PMC: PMC8320893
Source: Self-asserted source
Stephen C. Frederico
grade
Preferred source (of 2)‎

Making a Cold Tumor Hot: The Role of Vaccines in the Treatment of Glioblastoma.

Frontiers in oncology
2021-05-10 | Journal article
DOI: 10.3389/fonc.2021.672508
PMID: 34041034
PMC: PMC8141615
Source: Self-asserted source
Stephen C. Frederico
grade
Preferred source (of 2)‎

Clinical correlates for immune checkpoint therapy: significance for CNS malignancies.

Neuro-oncology advances
2020-11-27 | Journal article
DOI: 10.1093/noajnl/vdaa161
PMID: 33506203
PMC: PMC7813206
Source: Self-asserted source
Stephen C. Frederico
grade
Preferred source (of 2)‎
How many people are using ORCID?